Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
2.
Exp Dermatol ; 29(6): 531-534, 2020 06.
Article in English | MEDLINE | ID: mdl-32298489

ABSTRACT

The patched tumor suppressor gene (PTCH1) encodes a receptor, which is a key component of the hedgehog signalling pathway. Mutations in PTCH1 are implicated in the development of sporadic basal cell carcinomas (BCC), as well as those in Gorlin Syndrome. Rarely, BCCs may develop in a linear pattern along lines of Blaschko due to cutaneous mosaicism. In cases in which there are other features of Gorlin syndrome, genomic analysis has demonstrated lesional mutations in the Hedgehog signalling pathway. Causative mutations, however, have not been firmly demonstrated in the cases of linear and segmental BCCs in otherwise healthy individuals. Herein, we report a case of a 31 year-old Caucasian woman with linear development of multiple superficial BCCs in a Blaschkoid distribution without other characteristic findings of Gorlin syndrome. Genomic analysis of lesional skin by whole-exome sequencing identified a novel heterozygous mutation PTCH1: NM_000264.3, Exon 15, c.2336-2337insGGTAGGA, p.Asp779Glufs*13 in PTCH1, shared by two discrete samples within the lesion, while no mutations were found in the non-lesional skin or peripheral blood. Given the young age of our patient and linear distribution of BCCs on non-sun exposed skin, our findings suggest segmental mosaicism. The patient was treated with topical 5% imiquimod with histologically confirmed clearance of BCCs in 2 months.


Subject(s)
Carcinoma, Basal Cell/genetics , Mosaicism , Patched-1 Receptor/genetics , Skin Neoplasms/genetics , Adult , Carcinoma, Basal Cell/pathology , Female , Heterozygote , Humans , Mutation , Skin Neoplasms/pathology
3.
Skinmed ; 18(6): 337-341, 2020.
Article in English | MEDLINE | ID: mdl-33397562

ABSTRACT

Striae distensae (SD) are associated with negative psychosocial effects. Improvements have been shown with non-ablative fractional lasers (NAFL). Topical peptides have also been effective in cutaneous rejuvenation; however, no studies have examined combination therapy for striae. Our study evaluated the efficacy and safety of a peri-procedural tripeptide/hexapeptide serum as an adjunct to 1540 nm NAFL for the treatment of SD in 10 patients. All patients reported subjective improvement. The addition of tripeptide/hexapep-tide serum increased the objective improvement, reduced the incidence of post-inflammatory hyperpigmentation, and increased patient satisfaction.


Subject(s)
Dermatologic Agents/therapeutic use , Low-Level Light Therapy/methods , Oligopeptides/therapeutic use , Striae Distensae/therapy , Adult , Combined Modality Therapy , Female , Humans , Male , Patient Satisfaction , Pilot Projects , Treatment Outcome
7.
J Invest Dermatol ; 139(2): 300-307, 2019 02.
Article in English | MEDLINE | ID: mdl-30291846

ABSTRACT

Activation of the hedgehog pathway is causative of virtually all sporadic and Gorlin syndrome-related basal cell carcinomas (BCCs), with loss of function of Ptc1 being the most common genomic lesion. Sporadic BCCs also overexpress Dsg2, a desmosomal cadherin normally found in the basal layer. Using a mouse model of Gorlin syndrome (Ptc1+/lacZ mice), we found that overexpressing Dsg2 in the basal layer (K14-Dsg2/Ptc1+/lacZ mice) or the superficial epidermis (Inv-Dsg2/Ptc1+/lacZ mice) resulted in increased spontaneous BCC formation at 3 and 6 months, respectively. The tumors did not show loss of heterozygosity of Ptc1, despite high levels of Gli1 and phosphorylated Stat3. A panel of sporadic human BCCs showed increased staining of both Dsg2 and phosphorylated Stat3 in all nine samples. Overexpression of Dsg2 in ASZ001 cells, a Ptc1-/- BCC cell line, induced Stat3 phosphorylation and further increased Gli1 levels, in both an autocrine and paracrine manner. Three different Stat3 inhibitors reduced viability and Gli1 expression in ASZ001 cells but not in HaCaT cells. Conversely, stimulation of Stat3 in ASZ001 cells with IL-6 increased Gli1 expression. Our results indicate that Dsg2 enhances canonical hedgehog signaling downstream of Ptc1 to promote BCC development through the activation of phosphorylated Stat3 and regulation of Gli1 expression.


Subject(s)
Basal Cell Nevus Syndrome/pathology , Desmoglein 2/metabolism , STAT3 Transcription Factor/metabolism , Skin Neoplasms/pathology , Animals , Basal Cell Nevus Syndrome/genetics , Cell Line, Tumor , Disease Models, Animal , Gene Knock-In Techniques , Hedgehog Proteins/metabolism , Humans , Mice , Mice, Transgenic , Patched-1 Receptor/genetics , Phosphorylation , STAT3 Transcription Factor/antagonists & inhibitors , Skin/pathology , Skin Neoplasms/genetics , Zinc Finger Protein GLI1/metabolism
8.
Skinmed ; 16(3): 199-200, 2018.
Article in English | MEDLINE | ID: mdl-29989542

ABSTRACT

A 78-year-old woman with a history of bilateral hip replacements presented with an ill-defined erythematous plaque with foci of reticulated and indurated areas on the left thigh. Initially, a few weeks after her surgery, a small area of erythema appeared overlying the incision site. Over a 6-month period, the erythema slowly expanded before stabilizing in size (Figure 1). There was no pruritus, pain, or warmth. Orthopedic evaluation found no evidence of infection or malfunction of the hip prosthesis. A skin biopsy revealed telangiectasia of the superficial vessels. Based on the clinical and histopathologic findings, a diagnosis of reticular telangiectatic erythema (RTE) was established. An ultrasound scan revealed a greater trochanteric bursa distended by a chronic, organized hematoma measuring 12 cm at greatest dimension, secondary to a full-thickness tear of the left gluteus minimus (Figure 2), establishing the underlying cause of the RTE in this patient.


Subject(s)
Arthroplasty, Replacement, Hip/adverse effects , Erythema/etiology , Hematoma/etiology , Postoperative Complications/etiology , Telangiectasis/etiology , Aged , Chronic Disease , Erythema/diagnosis , Erythema/therapy , Female , Hematoma/diagnosis , Hematoma/therapy , Humans , Postoperative Complications/diagnosis , Postoperative Complications/therapy , Telangiectasis/diagnosis , Telangiectasis/therapy
9.
J Invest Dermatol ; 138(11): 2470-2479, 2018 11.
Article in English | MEDLINE | ID: mdl-29753032

ABSTRACT

In addition to playing a role in adhesion, desmoglein 2 (Dsg2) is an important regulator of growth and survival signaling pathways, cell proliferation, migration and invasion, and oncogenesis. Although low-level Dsg2 expression is observed in basal keratinocytes and is downregulated in nonhealing venous ulcers, overexpression has been observed in both melanomas and nonmelanoma malignancies. Here, we show that transgenic mice overexpressing Dsg2 in basal keratinocytes primed the activation of mitogenic pathways, but did not induce dramatic epidermal changes or susceptibility to chemical-induced tumor development. Interestingly, acceleration of full-thickness wound closure and increased wound-adjacent keratinocyte proliferation was observed in these mice. As epidermal cytokines and their receptors play critical roles in wound healing, Dsg2-induced secretome alterations were assessed with an antibody profiler array and revealed increased release and proteolytic processing of the urokinase-type plasminogen activator receptor. Dsg2 induced urokinase-type plasminogen activator receptor expression in the skin of transgenic compared with wild-type mice. Wounding further enhanced urokinase-type plasminogen activator receptor in both epidermis and dermis with a concomitant increase in the prohealing laminin-332, a major component of the basement membrane zone, in transgenic mice. This study demonstrates that Dsg2 induces epidermal activation of various signaling cascades and accelerates cutaneous wound healing, in part, through urokinase-type plasminogen activator receptor-related signaling cascades.


Subject(s)
Desmoglein 2/metabolism , Keratinocytes/physiology , Receptors, Urokinase Plasminogen Activator/metabolism , Skin/pathology , Wound Healing/genetics , Animals , Cell Adhesion Molecules/metabolism , Cell Proliferation , Cells, Cultured , Desmoglein 2/genetics , Humans , Mice , Mice, Inbred C57BL , Mice, Transgenic , Signal Transduction , Skin/metabolism , Kalinin
10.
Oncotarget ; 7(25): 37536-37555, 2016 Jun 21.
Article in English | MEDLINE | ID: mdl-26918609

ABSTRACT

The desmosomal cadherin, desmoglein 2 (Dsg2), is deregulated in a variety of human cancers including those of the skin. When ectopically expressed in the epidermis of transgenic mice, Dsg2 activates multiple mitogenic signaling pathways and increases susceptibility to tumorigenesis. However, the molecular mechanism responsible for Dsg2-mediated cellular signaling is poorly understood. Here we show overexpression as well as co-localization of Dsg2 and EGFR in cutaneous SCCs in vivo. Using HaCaT keratinocytes, knockdown of Dsg2 decreases EGFR expression and abrogates the activation of EGFR, c-Src and Stat3, but not Erk1/2 or Akt, in response to EGF ligand stimulation. To determine whether Dsg2 mediates signaling through lipid microdomains, sucrose density fractionation illustrated that Dsg2 is recruited to and displaces Cav1, EGFR and c-Src from light density lipid raft fractions. STED imaging confirmed that the presence of Dsg2 disperses Cav1 from the cell-cell borders. Perturbation of lipid rafts with the cholesterol-chelating agent MßCD also shifts Cav1, c-Src and EGFR out of the rafts and activates signaling pathways. Functionally, overexpression of Dsg2 in human SCC A431 cells enhances EGFR activation and increases cell proliferation and migration through a c-Src and EGFR dependent manner. In summary, our data suggest that Dsg2 stimulates cell growth and migration by positively regulating EGFR level and signaling through a c-Src and Cav1-dependent mechanism using lipid rafts as signal modulatory platforms.


Subject(s)
Caveolin 1/metabolism , Desmoglein 2/biosynthesis , ErbB Receptors/biosynthesis , src-Family Kinases/metabolism , CSK Tyrosine-Protein Kinase , Caveolin 1/genetics , Cell Line, Tumor , Cell Movement/physiology , Cell Proliferation/physiology , Desmoglein 2/genetics , Desmoglein 2/metabolism , ErbB Receptors/genetics , ErbB Receptors/metabolism , Fibrosarcoma/genetics , Fibrosarcoma/metabolism , Humans , Membrane Microdomains/enzymology , Membrane Microdomains/metabolism , Signal Transduction , Skin Neoplasms/genetics , Skin Neoplasms/metabolism , Up-Regulation , src-Family Kinases/genetics
11.
J Cell Sci ; 127(Pt 17): 3782-93, 2014 Sep 01.
Article in English | MEDLINE | ID: mdl-25002405

ABSTRACT

Desmosomes are prominent adhesive junctions found in various epithelial tissues. The cytoplasmic domains of desmosomal cadherins interact with a host of desmosomal plaque proteins, including plakophilins, plakoglobin and desmoplakin, which, in turn, recruit the intermediate filament cytoskeleton to sites of cell-cell contact. Although the individual components of the desmosome are known, mechanisms regulating the assembly of this junction are poorly understood. Protein palmitoylation is a posttranslational lipid modification that plays an important role in protein trafficking and function. Here, we demonstrate that multiple desmosomal components are palmitoylated in vivo. Pharmacologic inhibition of palmitoylation disrupts desmosome assembly at cell-cell borders. We mapped the site of plakophilin palmitoylation to a conserved cysteine residue present in the armadillo repeat domain. Mutation of this single cysteine residue prevents palmitoylation, disrupts plakophilin incorporation into the desmosomal plaque and prevents plakophilin-dependent desmosome assembly. Finally, plakophilin mutants unable to become palmitoylated act in a dominant-negative manner to disrupt proper localization of endogenous desmosome components and decrease desmosomal adhesion. Taken together, these data demonstrate that palmitoylation of desmosomal components is important for desmosome assembly and adhesion.


Subject(s)
Cell Movement/physiology , Desmosomes/metabolism , Lipoylation/physiology , Plakophilins/metabolism , Cell Line, Tumor , Desmoplakins/metabolism , Humans , gamma Catenin/metabolism
12.
Methods Mol Biol ; 1195: 133-44, 2014.
Article in English | MEDLINE | ID: mdl-24504930

ABSTRACT

Our understanding of the plasma membrane has markedly increased since Singer and Nicolson proposed the fluid mosaic model in 1972. While their revolutionary theory of the lipid bilayer remains largely valid, it is now known that lipids and proteins are not randomly dispersed throughout the plasma membrane but instead may be organized within membrane microdomains, commonly referred to as lipid rafts. Lipid rafts are highly dynamic, detergent resistant, and enriched with both cholesterol and glycosphingolipids. The two main types are flotillin-rich planar lipid rafts and caveolin-rich caveolae. It is proposed that flotillin and caveolin proteins regulate cell communication by compartmentalizing and interacting with signal transduction proteins within their respective lipid microdomains. Consequently, membrane rafts play an important role in vital cellular functions including migration, invasion, and signaling; thus, alterations in their microenvironment can initiate signaling pathways that affect cellular function and behavior. Therefore, the identification of lipid rafts and their associated proteins is integral to the study of transmembrane signaling. Here, we review the current standard protocols and biochemical approaches used to isolate and define raft proteins from epithelial cells and tissues. Furthermore, in Section 3 of this chapter, detailed protocols are offered for isolating lipid rafts by subjection to detergent and sucrose density centrifugation, as well as an approach for selectively isolating caveolae. Methods to manipulate rafts with treatments such as methyl-ß-cyclodextrin and flotillin III are also described.


Subject(s)
Cell Fractionation/methods , Detergents/pharmacology , Drug Resistance , Keratinocytes/cytology , Membrane Microdomains/drug effects , Cell Line , Cholesterol/metabolism , Epithelial Cells/cytology , Epithelial Cells/drug effects , Humans , Keratinocytes/drug effects , Membrane Microdomains/metabolism , Membrane Proteins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...